Computational fragment-based binding site identification by ligand competitive saturation.

Fragment-based drug discovery using NMR and x-ray crystallographic methods has proven utility but also non-trivial time, materials, and labor costs. Current computational fragment-based approaches circumvent these issues but suffer from limited representations of protein flexibility and solvation ef...

Full description

Bibliographic Details
Main Authors: Olgun Guvench, Alexander D MacKerell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-07-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC2700966?pdf=render
id doaj-a340b742ed7e4fc2af4d06d3ae8b05dd
record_format Article
spelling doaj-a340b742ed7e4fc2af4d06d3ae8b05dd2020-11-25T01:57:43ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582009-07-0157e100043510.1371/journal.pcbi.1000435Computational fragment-based binding site identification by ligand competitive saturation.Olgun GuvenchAlexander D MacKerellFragment-based drug discovery using NMR and x-ray crystallographic methods has proven utility but also non-trivial time, materials, and labor costs. Current computational fragment-based approaches circumvent these issues but suffer from limited representations of protein flexibility and solvation effects, leading to difficulties with rigorous ranking of fragment affinities. To overcome these limitations we describe an explicit solvent all-atom molecular dynamics methodology (SILCS: Site Identification by Ligand Competitive Saturation) that uses small aliphatic and aromatic molecules plus water molecules to map the affinity pattern of a protein for hydrophobic groups, aromatic groups, hydrogen bond donors, and hydrogen bond acceptors. By simultaneously incorporating ligands representative of all these functionalities, the method is an in silico free energy-based competition assay that generates three-dimensional probability maps of fragment binding (FragMaps) indicating favorable fragment:protein interactions. Applied to the two-fold symmetric oncoprotein BCL-6, the SILCS method yields two-fold symmetric FragMaps that recapitulate the crystallographic binding modes of the SMRT and BCOR peptides. These FragMaps account both for important sequence and structure differences in the C-terminal halves of the two peptides and also the high mobility of the BCL-6 His116 sidechain in the peptide-binding groove. Such SILCS FragMaps can be used to qualitatively inform the design of small-molecule inhibitors or as scoring grids for high-throughput in silico docking that incorporate both an atomic-level description of solvation and protein flexibility.http://europepmc.org/articles/PMC2700966?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Olgun Guvench
Alexander D MacKerell
spellingShingle Olgun Guvench
Alexander D MacKerell
Computational fragment-based binding site identification by ligand competitive saturation.
PLoS Computational Biology
author_facet Olgun Guvench
Alexander D MacKerell
author_sort Olgun Guvench
title Computational fragment-based binding site identification by ligand competitive saturation.
title_short Computational fragment-based binding site identification by ligand competitive saturation.
title_full Computational fragment-based binding site identification by ligand competitive saturation.
title_fullStr Computational fragment-based binding site identification by ligand competitive saturation.
title_full_unstemmed Computational fragment-based binding site identification by ligand competitive saturation.
title_sort computational fragment-based binding site identification by ligand competitive saturation.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2009-07-01
description Fragment-based drug discovery using NMR and x-ray crystallographic methods has proven utility but also non-trivial time, materials, and labor costs. Current computational fragment-based approaches circumvent these issues but suffer from limited representations of protein flexibility and solvation effects, leading to difficulties with rigorous ranking of fragment affinities. To overcome these limitations we describe an explicit solvent all-atom molecular dynamics methodology (SILCS: Site Identification by Ligand Competitive Saturation) that uses small aliphatic and aromatic molecules plus water molecules to map the affinity pattern of a protein for hydrophobic groups, aromatic groups, hydrogen bond donors, and hydrogen bond acceptors. By simultaneously incorporating ligands representative of all these functionalities, the method is an in silico free energy-based competition assay that generates three-dimensional probability maps of fragment binding (FragMaps) indicating favorable fragment:protein interactions. Applied to the two-fold symmetric oncoprotein BCL-6, the SILCS method yields two-fold symmetric FragMaps that recapitulate the crystallographic binding modes of the SMRT and BCOR peptides. These FragMaps account both for important sequence and structure differences in the C-terminal halves of the two peptides and also the high mobility of the BCL-6 His116 sidechain in the peptide-binding groove. Such SILCS FragMaps can be used to qualitatively inform the design of small-molecule inhibitors or as scoring grids for high-throughput in silico docking that incorporate both an atomic-level description of solvation and protein flexibility.
url http://europepmc.org/articles/PMC2700966?pdf=render
work_keys_str_mv AT olgunguvench computationalfragmentbasedbindingsiteidentificationbyligandcompetitivesaturation
AT alexanderdmackerell computationalfragmentbasedbindingsiteidentificationbyligandcompetitivesaturation
_version_ 1724972903575846912